FI104724B - Menetelmä aprotiniinivarianttien valmistamiseksi - Google Patents

Menetelmä aprotiniinivarianttien valmistamiseksi Download PDF

Info

Publication number
FI104724B
FI104724B FI904474A FI904474A FI104724B FI 104724 B FI104724 B FI 104724B FI 904474 A FI904474 A FI 904474A FI 904474 A FI904474 A FI 904474A FI 104724 B FI104724 B FI 104724B
Authority
FI
Finland
Prior art keywords
aprotinin
yeast
variants
val
ala
Prior art date
Application number
FI904474A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI904474A0 (fi
Inventor
Michael Schedel
Juergen Ebbers
Dietrich Hoerlein
Rathindra Das
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI904474A0 publication Critical patent/FI904474A0/fi
Application granted granted Critical
Publication of FI104724B publication Critical patent/FI104724B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • C07K14/8117—Bovine/basic pancreatic trypsin inhibitor (BPTI, aprotinin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI904474A 1989-09-13 1990-09-11 Menetelmä aprotiniinivarianttien valmistamiseksi FI104724B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3930522A DE3930522A1 (de) 1989-09-13 1989-09-13 Rekombinante aprotinin-varianten - gentechnisches verfahren zur mikrobiellen herstellung von homogen prozessierten aprotinin-varianten sowie die therapeutische anwendung derselben
DE3930522 1989-09-13

Publications (2)

Publication Number Publication Date
FI904474A0 FI904474A0 (fi) 1990-09-11
FI104724B true FI104724B (fi) 2000-03-31

Family

ID=6389306

Family Applications (1)

Application Number Title Priority Date Filing Date
FI904474A FI104724B (fi) 1989-09-13 1990-09-11 Menetelmä aprotiniinivarianttien valmistamiseksi

Country Status (15)

Country Link
US (1) US5164482A (da)
EP (1) EP0419878B1 (da)
JP (1) JP2916228B2 (da)
KR (1) KR0169976B1 (da)
AT (1) ATE113074T1 (da)
AU (1) AU632361B2 (da)
CA (1) CA2025070C (da)
DD (1) DD299311A5 (da)
DE (2) DE3930522A1 (da)
DK (1) DK0419878T3 (da)
ES (1) ES2062235T3 (da)
FI (1) FI104724B (da)
HU (1) HU213582B (da)
IL (1) IL95618A (da)
ZA (1) ZA907266B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2208511A (en) * 1987-08-07 1989-04-05 Bayer Ag Variants of bovine pancreatic trypsin inhibitor produced by recombinant dna technology
US5591603A (en) * 1987-08-28 1997-01-07 Novo Nordisk A/S Process for preparing aprotinin and aprotinin analogs in yeast cells
DK450187D0 (da) * 1987-08-28 1987-08-28 Novo Industri As Fremgangsmaade til fremstilling af proteiner
US5056341A (en) * 1989-06-08 1991-10-15 Sanyo Electric Co., Ltd. Washing machine
US5231010A (en) * 1989-09-13 1993-07-27 Bayer Aktiengesellschaft Recombinant aprotinin variants genetically engineered process for the microbial preparation of homogeneously processed aprotinin variants and the therapeutic use thereof
IL99585A0 (en) * 1990-10-01 1992-08-18 Novo Nordisk As Aprotinin analogues,their production and pharmaceutical compositions containing them
DE4417353A1 (de) * 1994-05-18 1996-01-25 Bayer Ag Verfahren zur Herstellung von rekombinantem Aprotinin und rekombinanten Aprotinin Varianten mit der natürlichen N-terminlaen Sequenz
US5786328A (en) * 1995-06-05 1998-07-28 Genentech, Inc. Use of kunitz type plasma kallikrein inhibitors
US5780265A (en) * 1995-06-05 1998-07-14 Genentech, Inc. Kunitz type plasma kallikrein inhibitors
DE19629982A1 (de) 1996-07-25 1998-01-29 Bayer Ag Aprotinin-Varianten mit verbesserten Eigenschaften
DE19725014A1 (de) * 1997-06-13 1998-12-17 Bayer Ag Aprotininvarianten mit verbesserten Eigenschaften und Bikunine von Aprotininvarianten
WO2003033009A2 (en) * 2001-07-10 2003-04-24 Omnio Ab Novel drug targets for arthritis
US20060218667A1 (en) * 2004-10-12 2006-09-28 Vojdani Fakhrieh S Plant-produced recombinant aprotinin and aprotinin variants
CA2619657C (en) 2005-09-16 2016-01-26 Bayer Cropscience Sa Transplastomic plants expressing lumen-targeted protein

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037806A (en) * 1985-02-22 1991-08-06 Monsanto Company Biologically active method using somatotropins
GB2188322A (en) * 1986-03-26 1987-09-30 Bayer Ag Aprotinin and analogues thereof produced by a recombinant host
GB2208511A (en) * 1987-08-07 1989-04-05 Bayer Ag Variants of bovine pancreatic trypsin inhibitor produced by recombinant dna technology
DK225488D0 (da) * 1988-04-26 1988-04-26 Novo Industri As Polypeptid
DK450187D0 (da) * 1987-08-28 1987-08-28 Novo Industri As Fremgangsmaade til fremstilling af proteiner

Also Published As

Publication number Publication date
HU213582B (en) 1997-08-28
EP0419878A1 (de) 1991-04-03
IL95618A0 (en) 1991-06-30
ZA907266B (en) 1991-07-31
IL95618A (en) 1996-09-12
CA2025070C (en) 2001-01-02
JPH03197496A (ja) 1991-08-28
US5164482A (en) 1992-11-17
EP0419878B1 (de) 1994-10-19
AU632361B2 (en) 1992-12-24
AU6245390A (en) 1991-03-21
KR0169976B1 (ko) 1999-02-01
FI904474A0 (fi) 1990-09-11
DK0419878T3 (da) 1994-11-21
JP2916228B2 (ja) 1999-07-05
ES2062235T3 (es) 1994-12-16
DE59007498D1 (de) 1994-11-24
HUT62031A (en) 1993-03-29
CA2025070A1 (en) 1991-03-14
KR910006483A (ko) 1991-04-29
ATE113074T1 (de) 1994-11-15
HU905877D0 (en) 1991-03-28
DE3930522A1 (de) 1991-03-21
DD299311A5 (de) 1992-04-09

Similar Documents

Publication Publication Date Title
FI104724B (fi) Menetelmä aprotiniinivarianttien valmistamiseksi
US5373090A (en) Aprotinin analogues and a process for the production thereof
US5407915A (en) Human Bikunin variants as proteinase inhibitors, and medicaments containing these
FI97139C (fi) Menetelmä haiman erittämän trypsiini-inhibiittorivarianttien valmistamiseksi ja menetelmässä käytettävä DNA, vektori ja isäntäsolu
JPS62272976A (ja) 変異組織プラスミノ−ゲンアクチベ−タ−及びその製造
IE61809B1 (en) Novel polypeptides with an anticoagulant activity
JPH06315384A (ja) セリンプロテアーゼインヒビターの産生のための遺伝子組み換え法と、同じ目的に有用なｄｎａ塩基配列
US5278285A (en) Variant of Kunitz-type inhibitor derived from the α3-chain of human type VI collagen produced by recombinant DNA technology
US5258302A (en) DNA for expression of aprotinin in methylotrophic yeast cells
US6090585A (en) Human collagenase inhibitor sequence, recombinant vector system for using same and recombinant-DNA method for the manufacture of same
US5231010A (en) Recombinant aprotinin variants genetically engineered process for the microbial preparation of homogeneously processed aprotinin variants and the therapeutic use thereof
US5661001A (en) High molecular weight desulphatohirudin
US5707831A (en) Process for preparing recombinant aprotinin and recombinant aprotinin variants having the natural N-terminal sequence
KR0134377B1 (ko) 에글린 b 및 에글린 c의 돌연변이체, 이를 암호화하는 dna 서열, 이러한 dna를 포함하는 재조합 벡터, 이러한 벡터로 형질전환된 숙주, 돌연변이체를 제조하는 방법 및 돌연변이체를 함유하는 약제학적 조성물
EP1002083A1 (de) Aprotininvarianten mit verbesserten eigenschaften und bikunine von aprotininvarianten
US5180667A (en) Genes encoding eglin C mutants
JP2672088B2 (ja) セリンプロテアーゼ阻害剤の生産のための遺伝子組み換え法と、同じ目的に有用なｄｎａ塩基配列

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: BAYER AKTIENGESELLSCHAFT